Literature DB >> 193042

Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodies.

F de Noronha, R Baggs, W Schäfer, D Bolognesi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193042     DOI: 10.1038/267054a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

1.  Suppression of leukemogenesis in hairless mice by anti-type C viral immune gamma globulins.

Authors:  R Pottathil; H Meier; R J Huebner
Journal:  Naturwissenschaften       Date:  1978-08

Review 2.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Expression of endogenous viral antigens during immune response.

Authors:  E Wecker
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

4.  Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats.

Authors:  W Schäfer; D P Bolognesi; F de Noronha; P J Fischinger; G Hunsmann; J N Ihle; V Moenning; H Schwarz; H J Thiel
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

5.  Effect of chemical modification and fragmentation on antigenic determinants of internal protein p30 and surface glycoprotein gp70 of type C retroviruses.

Authors:  R J Versteegen; S Oroszlan
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

6.  Selective host range restriction of goat cells for recombinant murine leukemia virus and feline leukemia virus type A.

Authors:  P J Fischinger; H J Thiel; C S Blevins; N M Dunlop
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  Rosettes from Friend leukemia virus envelope: preparation and physicochemical and partial biological characterization.

Authors:  J Schneider; H Schwarz; G Hunsmann
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

8.  Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection.

Authors:  K Ljunggren; A Karlson; E M Fenyö; M Jondal
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.